In the News

Share

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

460 News Items found
A researcher working in an MSK lab
MSK Research Highlights September 18, 2024

New MSK research uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and finds a commercially available contrast dye could help surgeons better separate cancer from healthy tissue.
Q&A
Smiling female doctor talking to patient.
6 Questions Answered about the CDH1 Gene Mutation & Stomach Cancer

Inheriting a mutation in the CDH1 gene can raise risk of a rare stomach cancer called hereditary diffuse gastric cancer.
In the Clinic
CAR T cell therapy
CAR T Cell Therapies Are a Growing Area of Research

Cell therapies that use patients’ own immune cells to attack cancer — including CAR T cell therapy, an approach developed at MSK — are a promising and rapidly growing area of research.
Finding
David Hyman and Robin Gillespie
#AACR17: Basket Trial for Experimental Drug Shows Promising Early Results

Neratinib, which targets mutations that drive cancer growth, is showing promise for treating several types of cancer.
Announcement
Omar Abdel-Wahab
New Grant Awarded to MSK for Efforts in Acute Myeloid Leukemia Research

The Specialized Programs of Research Excellence (SPORE) grant will fund efforts focusing on the development of new treatments.
Dr. Alexander Drilon
FDA Grants Accelerated Approval to Repotrectinib for Cancers with NTRK Fusions 

The FDA has approved the targeted drug repotrectinib for patients 12 and older with tumors that carry gene changes called NTRK fusions. The trial that resulted in the approval was led by MSK investigators.
In the News
MSK medical oncologist Eileen O'Reilly with a patient
ASCO 2019: PARP Inhibitors Benefit People with Pancreatic Cancer Who Have a BRCA Mutation

Results from a large phase III clinical trial unveiled at this year’s ASCO meeting identify an effective targeted therapy for a subset of people with pancreatic cancer.
fruits and vegetables
Food Insecurity Can Make Healthy Eating Difficult for People with Cancer: How MSK is Helping Diverse Communities

Discover how Memorial Sloan Kettering is teaming up with local hospitals to promote healthy eating in diverse communities.
Finding
Genetic counselor Elise Fiala and pediatric cancer expert Michael Walsh
Study Demonstrates the Reasons to Screen Children with Cancer for Inherited Cancer Genes

The largest study of its kind to look at data from children with cancer finds inherited cancer genes are more common than expected.
Feature
woman against grey background with her head in her hands
Coping with Shame Related to Cancer

Find out how to handle feelings of self-blame and shame that may accompany a cancer diagnosis.